News & Updates

Consistent benefits with lecanemab seen in Clarity AD Asian cohort
Consistent benefits with lecanemab seen in Clarity AD Asian cohort
19 Apr 2025 byJairia Dela Cruz

In the treatment of early Alzheimer’s disease (AD), lecanemab is as safe and efficacious in Asian patients as in the wider Clarity AD population, slowing cognitive decline and reducing amyloid levels in the brain with manageable risks.

Consistent benefits with lecanemab seen in Clarity AD Asian cohort
19 Apr 2025
Etripamil nasal spray safe, effective against PSVT
Etripamil nasal spray safe, effective against PSVT
19 Apr 2025
LBB performs better than standard BiV pacing for CRT in chronic heart failure
LBB performs better than standard BiV pacing for CRT in chronic heart failure
17 Apr 2025 byJairia Dela Cruz

For chronic heart failure patients requiring cardiac resynchronization therapy (CRT), the use of left bundle branch (LBB) pacing yields superior clinical outcomes compared with the traditional biventricular (BiV) pacing, as shown in the results of the HeartSync-LBBP trial.

LBB performs better than standard BiV pacing for CRT in chronic heart failure
17 Apr 2025